Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
When would you recommend postmastectomy radiation to a male, status post mastectomy with 1/1 sentinel nodes with ITCs?
Answer from: Radiation Oncologist at Community Practice
Upfront ITC is not an indication for PMRT unless indicated for T factor. ITC after chemo, would treat like node-positive with PMRT.
Sign In
or
Register
to read more
Answer from: Radiation Oncologist at Community Practice
If T1-T2 with ITCs, I would not recommend PMRT. If T3 with ITCs, I would discuss the pros/cons and favor if ER-. If T4, I would recommend.
Comments
Radiation Oncologist at Radiation Oncology Associates P.C.
Would the presence of ITCs in multiple sentinel no...
Radiation Oncologist at Allegheny Health Network, Pittsburgh
It would not. As Dr. @Sushil Beriwal noted, i...
Radiation Oncologist at Radiation Oncology Associates P.C.
Thank you.
3872
3877
3887
Sign In
or
Register
to read more
Answer from: Radiation Oncologist at Community Practice
For those seeking reference data on the above question, here are a couple: Karam et al., PMID 24035330 Mittendorf et al., PMID 25488970
Sign In
or
Register
to read more
9093
9088
10713
Related Questions
How does a pathological CR to neoadjuvant chemotherapy influence your practice for the use of bolus with adjuvant PMRT patients without inflammatory breast cancer, but who would meet traditional risk factors for skin involvement?
Does your dosimetrist use skin flash for VMAT whole breast or RNI plans?
Given the new ASCO guidelines on SNB in early stage breast cancer, how does the omission of SNB in patients aged 50-70 impact your adjuvant radiation recommendations?
Given the 10-year outcomes of UK FAST-Forward presented at ESTRO, how have you expanded the use of ultra-hypofractionation in your practice?
How do you assess and counsel women with chronic post-lumpectomy or mastectomy pain?
How do you manage symptomatic fat necrosis following adjuvant breast radiotherapy?
How do you approach reirradiation in a patient who underwent breast-conserving surgery for recurrent breast cancer after initial lumpectomy and APBI?
How would you approach a patient with a 12 mm recurrence of the left implant-based breast reconstruction 17 years after her initial diagnosis?
Is it reasonable to extrapolate the findings of RT Charm and Alliance to intact breast patients and offer hypofractionated RNI to all patients who are eligible for RNI?
What is your approach to women with breast cancer who opts for a staged approach with up-front lumpectomy and SLN biopsy (pN-) when there are indications for adjuvant radiation therapy but she plans for a later mastectomy (=>6 months)?